Differential Virulence Gene Expression of Group A Streptococcus Serotype M3 in Response to Co-Culture with Moraxella catarrhalis

Streptococcus pyogenes (group A Streptococcus, GAS) and Moraxella catarrhalis are important colonizers and (opportunistic) pathogens of the human respiratory tract. However, current knowledge regarding colonization and pathogenic potential of these two pathogens is based on work involving single bacterial species, even though the interplay between respiratory bacterial species is increasingly important in niche occupation and the development of disease. Therefore, to further define and understand polymicrobial species interactions, we investigated whether gene expression (and hence virulence potential) of GAS would be affected upon co-culture with M. catarrhalis. For co-culture experiments, GAS and M. catarrhalis were cultured in Todd-Hewitt broth supplemented with 0.2% yeast extract (THY) at 37°C with 5% CO2 aeration. Each strain was grown in triplicate so that triplicate experiments could be performed. Bacterial RNA was isolated, cDNA synthesized, and microarray transcriptome expression analysis performed. We observed significantly increased (≥4-fold) expression for genes playing a role in GAS virulence such as hyaluronan synthase (hasA), streptococcal mitogenic exotoxin Z (smeZ) and IgG endopeptidase (ideS). In contrast, significantly decreased (≥4-fold) expression was observed in genes involved in energy metabolism and in 12 conserved GAS two-component regulatory systems. This study provides the first evidence that M. catarrhalis increases GAS virulence gene expression during co-culture, and again shows the importance of polymicrobial infections in directing bacterial virulence.

[1]  K. Riesbeck,et al.  Genome Analysis of Moraxella catarrhalis Strain RH4, a Human Respiratory Tract Pathogen , 2012 .

[2]  L. Drago,et al.  Nasopharyngeal Biofilm-Producing Otopathogens in Children with Nonsevere Recurrent Acute Otitis Media , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[3]  R. Olsen,et al.  An amino‐terminal signal peptide of Vfr protein negatively influences RopB‐dependent SpeB expression and attenuates virulence in Streptococcus pyogenes , 2011, Molecular microbiology.

[4]  M. Federle,et al.  Two Group A Streptococcal Peptide Pheromones Act through Opposing Rgg Regulators to Control Biofilm Development , 2011, PLoS pathogens.

[5]  Therése Nordström,et al.  Moraxella catarrhalis Outer Membrane Vesicles Carry β-Lactamase and Promote Survival of Streptococcus pneumoniae and Haemophilus influenzae by Inactivating Amoxicillin , 2011, Antimicrobial Agents and Chemotherapy.

[6]  J. Musser,et al.  Distinct signatures of diversifying selection revealed by genome analysis of respiratory tract and invasive bacterial populations , 2011, Proceedings of the National Academy of Sciences.

[7]  A. Hofman,et al.  Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae. , 2011, Microbiology.

[8]  E. Garcia-Melchor,et al.  Necrotizing fasciitis and myositis caused by streptococcal flesh-eating bacteria. , 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[9]  W. Swords,et al.  Interspecies bacterial communication as a target for therapy in otitis media , 2010, Expert review of anti-infective therapy.

[10]  V. Nizet,et al.  M Protein and Hyaluronic Acid Capsule Are Essential for In Vivo Selection of covRS Mutations Characteristic of Invasive Serotype M1T1 Group A Streptococcus , 2010, mBio.

[11]  C. Doern,et al.  Loss of the Group A Streptococcus Regulator Srv Decreases Biofilm Formation In Vivo in an Otitis Media Model of Infection , 2010, Infection and Immunity.

[12]  Richard A. Juneau,et al.  Indirect Pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in Polymicrobial Otitis Media Occurs via Interspecies Quorum Signaling , 2010, mBio.

[13]  A. Norrby-Teglund,et al.  Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Musser,et al.  Adaptation of Group A Streptococcus to Human Amniotic Fluid , 2010, PloS one.

[15]  S. Esposito,et al.  Insights into infectious otitis media. , 2010, International journal of immunopathology and pharmacology.

[16]  Allan W Cripps,et al.  Otitis media: viruses, bacteria, biofilms and vaccines , 2009, The Medical journal of Australia.

[17]  A. S. Attia,et al.  Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis , 2009, BMC Microbiology.

[18]  J. Musser,et al.  Transcriptome Adaptation of Group B Streptococcus to Growth in Human Amniotic Fluid , 2009, PloS one.

[19]  L. Björck,et al.  Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant. , 2009, Bioorganic & medicinal chemistry.

[20]  M. Pichichero,et al.  Adherence of Streptococcus pyogenes to human epithelial cells is modulated by Haemophilus influenzae , 2009, Scandinavian journal of infectious diseases.

[21]  A. Vergison Microbiology of otitis media: A moving target , 2008, Vaccine.

[22]  J. Musser,et al.  Extensive Adaptive Changes Occur in the Transcriptome of Streptococcus agalactiae (Group B Streptococcus) in Response to Incubation with Human Blood , 2008, PloS one.

[23]  U. von Pawel-Rammingen,et al.  The streptococcal protease IdeS modulates bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime polymorphonuclear leucocytes. , 2008, Molecular immunology.

[24]  J. Musser,et al.  A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus , 2008, Proceedings of the National Academy of Sciences.

[25]  T. Ross,et al.  Effect of relative inoculum concentration on Listeria monocytogenes growth in co-culture. , 2008, International journal of food microbiology.

[26]  M. Cunningham Pathogenesis of group A streptococcal infections and their sequelae. , 2008, Advances in experimental medicine and biology.

[27]  H. Gnehm,et al.  Mastoiditis in children: a prospective, observational study comparing clinical presentation, microbiology, computed tomography, surgical findings and histology , 2008, European Journal of Pediatrics.

[28]  D. Rasko,et al.  Metabolic Analysis of Moraxella catarrhalis and the Effect of Selected In Vitro Growth Conditions on Global Gene Expression , 2007, Infection and Immunity.

[29]  J. Musser,et al.  Regulation of Polysaccharide Utilization Contributes to the Persistence of Group A Streptococcus in the Oropharynx , 2007, Infection and Immunity.

[30]  M. Caparon,et al.  Comparative functional analysis of the lac operons in Streptococcus pyogenes , 2007, Molecular microbiology.

[31]  S. Sriskandan,et al.  Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. , 2007, The international journal of biochemistry & cell biology.

[32]  J. Musser,et al.  Expression Microarray and Mouse Virulence Analysis of Four Conserved Two-Component Gene Regulatory Systems in Group A Streptococcus , 2006, Infection and Immunity.

[33]  Edward A Graviss,et al.  Genome-Wide Analysis of Group A Streptococci Reveals a Mutation That Modulates Global Phenotype and Disease Specificity , 2006, PLoS pathogens.

[34]  J. Musser,et al.  Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. R. Lafontaine,et al.  Moraxella catarrhalis Coaggregates with Streptococcus pyogenes and Modulates Interactions of S. pyogenes with Human Epithelial Cells , 2004, Infection and Immunity.

[36]  J. Musser,et al.  Group A Streptococcus Gene Expression in Humans and Cynomolgus Macaques with Acute Pharyngitis , 2003, Infection and Immunity.

[37]  L. Björck,et al.  IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. , 2003, Current opinion in microbiology.

[38]  M. Wessels,et al.  Cytotoxic Effects of Streptolysin O and Streptolysin S Enhance the Virulence of Poorly Encapsulated Group A Streptococci , 2003, Infection and Immunity.

[39]  John D. Fraser,et al.  The Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of Streptococcus pyogenes1 , 2002, The Journal of Immunology.

[40]  Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. , 2001, Journal of bacteriology.

[41]  B. Kreikemeyer,et al.  Group A streptococcal growth phase‐associated virulence factor regulation by a novel operon (Fas) with homologies to two‐component‐type regulators requires a small RNA molecule , 2001, Molecular microbiology.

[42]  M. Cunningham,et al.  Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[43]  B. Carpentier,et al.  Limitation of adhesion and growth of Listeria monocytogenes on stainless steel surfaces by Staphylococcus sciuri biofilms , 2000, Journal of applied microbiology.

[44]  P. Bremer,et al.  Survival of Streptococcus pyogenes under stress and starvation. , 1999, FEMS microbiology letters.

[45]  J. Struthers,et al.  Interaction of Streptococcus pneumoniae andMoraxella catarrhalis: Investigation of the Indirect Pathogenic Role of β-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System , 1998, Antimicrobial Agents and Chemotherapy.

[46]  W. Traub,et al.  Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs. , 1997, Chemotherapy.

[47]  J. Verhoef,et al.  Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. , 1994, The Journal of infectious diseases.

[48]  G. Doern Branhamella catarrhalis: phenotypic characteristics. , 1990, The American journal of medicine.

[49]  J. Alouf,et al.  Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). , 1980, Pharmacology & therapeutics.